1. Research Funding
  2. Division of Discovery Science & Technology (Bioengineering)

Division of Discovery Science & Technology (Bioengineering)

This division supports the development and demonstration of modular platform technologies and engineering approaches to manipulate and interface with biology to enable a new paradigm of biomedical intervention for human health, without preference for any disease or application.

Program Areas: Early-Stage Innovation Cluster

Biochemical Engineering

Luisa Russell, Ph.D.

Bioelectromagnetic Engineering

Moria Fisher Bittmann, Ph.D.

Biomechanical Engineering

Moria Fisher Bittmann, Ph.D.

Biophotonic Engineering

David Rampulla, Ph.D.

Biomimetic Systems

Luisa Russell, Ph.D.

Rehabilitation Engineering

Michael Wolfson, Ph.D.

Mathematical Modeling

Grace C.Y. Peng, Ph.D.

Robotic Systems

Moria Fisher Bittmann, Ph.D.

illustration synthetic biology process

David Rampulla, Ph.D.

Program Areas: Translation and Commercialization Cluster

Resource Centers for Bioengineering Technologies

Ilana Goldberg, Ph.D.

Small Business

Ilana Goldberg, Ph.D.

Collaborations

An important aspect of the Institute’s mission is encouraging collaborations among the institutes and centers at NIH, other federal agencies, and the private sector.

  • Interagency Modeling and Analysis Group (IMAG) – IMAG brings together program officers across federal agencies to communicate, disseminate, and plan collaborative activities and joint initiatives related to computational and analytical modeling and analysis of biomedical, biological, and behavioral systems, see IMAG Research. IMAG also hosts the NIH Population Modeling Scientific Interest Group and the Multi-scale Modeling (MSM) Consortium.
     
  • Synthetic Biology Consortium (SBC) - The SBC is a trans-NIH effort to foster collaborations among researchers and share synthetic biology technologies to address unmet needs in biology and medicine.

Division Staff

Related News

  • NIH to evaluate COVID-19 at-home testing system

    Press Releases ·

    diagnostic test in a box
    An NIH-funded research team has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which received FDA emergency use authorization for use with a prescription.

  • Ionic liquid uniformly delivers chemotherapy to tumors while destroying cancerous tissue

    Grantee News ·

    Vascular and interventional radiologists report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab. This discovery could solve a problem that has long plagued drug delivery to tumors.

  • New skin patch brings us closer to wearable, all-in-one health monitor

    Grantee News ·

    Engineers have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol or caffeine. It is the first wearable device that monitors cardiovascular signals and multiple biochemical levels in the human body at the same time.

  • Exercising muscle combats chronic inflammation on its own

    Grantee News ·

    Biomedical engineers have demonstrated that human muscle has an innate ability to ward off damaging effects of chronic inflammation when exercised. The discovery was made possible through the use of lab-grown, engineered human muscle, demonstrating the potential power of the first-of-its-kind platform in such research endeavors.

  • DNA-editing method shows promise to treat mouse model of progeria

    Grantee News ·

    Researchers have successfully used a DNA-editing technique to extend the lifespan of mice with the genetic variation associated with progeria, a rare genetic disease that causes extreme premature aging in children and can significantly shorten their life expectancy.
View All News